Alvotech ALVO
NASDAQ ALVO
$5.18 -0.01 (-0.29%)
As of: Sep 9, 2026 · 12:25 PM EDT

Alvotech (ALVO) Revenue (2022 - 2026)

Alvotech's (ALVO) quarterly Revenue came in at $54.8 million in Q2 2026, down 42.25% on a YoY basis from $94.8 million in Q2 2025, and up 6.99% quarter-over-quarter from $51.2 million in Q1 2026.

Analysis

Alvotech (ALVO) Revenue (2022 - 2026) Analysis & Trends

Alvotech (ALVO) has reported Revenue for 5 consecutive years, with $54.8 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Revenue fell 42.25% year-over-year to $54.8 million; the trailing twelve-month figure through Jun 2026 stood at $343.3 million (up 3.18% YoY), and the FY2025 full-year result was $276.3 million, up 1.02% from the prior year.
  • Revenue grew to $54.8 million in Q2 2026 per ALVO's latest filing, from $51.2 million in the prior quarter.
  • Across five years, Revenue topped out at $204.7 million in Q4 2025 and bottomed at $3.9 million in Q3 2022.
  • Historically, Revenue has averaged $52.1 million across 5 years, with a median of $42.9 million in 2022.
  • The sharpest annual moves came in 2023 and 2025: Revenue sank 80.23% in 2023, then soared 784.21% in 2025.
  • Over 5 years, Revenue stood at $3.9 million in 2022, then jumped by 380.65% to $18.9 million in 2023, then soared by 248.76% to $65.9 million in 2024, then jumped by 210.62% to $204.7 million in 2025, then sank by 73.25% to $54.8 million in 2026.
  • According to Business Quant data, Revenue over the past three periods registered $54.8 million, $51.2 million, and $204.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Teva Pharmaceutical Industries 42.74 Bn 39.09 Bn 2.15 Bn 4.14 Bn
2 Viatris 19.19 Bn 18.31 Bn 1.46 Bn 3.76 Bn
3 Dr Reddys Laboratories 9.85 Bn 9.68 Bn 396.53 Mn 852.47 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn 796.20 Mn
5 Bausch Health Companies 2.38 Bn 543.21 Mn 2.10 Bn 2.85 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn 54.76 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 266.04 Mn
8 Amphastar Pharmaceuticals 993.77 Mn 703.65 Mn 93.47 Mn 183.90 Mn
9 Fennec Pharmaceuticals 408.67 Mn 367.42 Mn 17.15 Mn 17.87 Mn
10 RedHill Biopharma 179.39 Mn 179.39 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 54.76 Mn
Mar 31, 2026 51.18 Mn
Dec 31, 2025 204.73 Mn
Sep 30, 2025 32.65 Mn
Jun 30, 2025 94.83 Mn
Mar 31, 2025 109.91 Mn
Dec 31, 2024 65.91 Mn
Sep 30, 2024 62.11 Mn
Jun 30, 2024 53.48 Mn
Mar 31, 2024 12.43 Mn
Dec 31, 2023 18.90 Mn
Aug 31, 2023 22.72 Mn
Jun 30, 2023 6.85 Mn
Dec 31, 2022 3.93 Mn
Aug 31, 2022 3.93 Mn
Jun 30, 2022 34.65 Mn